Greenyn Biotechnology Co., Ltd (TPEX:6846)
Taiwan · Delayed Price · Currency is TWD 63.20
-1.20 (-1.86%)
Jul 14, 2026, 12:42 PM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.74 billion as of July 14, 2026. Its market cap has decreased by -17.33% in one year.
Market Cap
1.74B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
63.20
Market Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.74B, a decrease of -14.21%. That is a compound annual growth rate of -3.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.74B | -12.38% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Bio Therapeutics | 2.28B |
| Sunny Pharmtech | 2.18B |
| HeXun Biosciences | 2.16B |
| Sunhawk Vision Biotech | 2.10B |
| Great Novel Therapeutics Biotech & Medicals | 2.09B |
| G&E Herbal Biotechnology | 2.06B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.96B |
| Synbio Tech | 1.70B |